$0.9811
-0.00480-0.49%
At close: -
$0.9800
-0.00110-0.11%
After Hours: Dec 20, 4:40 PM EDT
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
There have been no specific sales or earnings guidance reported for Achilles Therapeutics in recent months.
Browse guidance and forecast on all stocks.